We supported a pharmaceutical startup in commercializing a novel over-the-counter therapeutic. Our team developed an end-to-end commercialization roadmap spanning regulatory strategy, clinical planning, manufacturing scale-up, and market positioning. Through an integrated, execution-focused approach, we reduced projected launch costs and timelines by more than 50% while strengthening investor readiness.‍

The result: Launch costs and timelines reduced by over 50%, improved regulatory and market clarity, and increased investor confidence to support scale-up.

We supported a global medical device company through a large-scale, cross-border acquisition. Our team established and led a dedicated IT Integration PMO, aligning thousands of employees and coordinating integration workstreams across geographies, functions, and systems. Through disciplined governance, standardized reporting, and sustained program leadership, we enabled consistent execution from due diligence throug hpost-integration.

The result: Strong integration governance, sustained deal momentum, and a proven, repeatable framework that drove value realization and fueled future growth.

Our team delivered results for a leading global biotech client developing a novel diagnostic platform. We led regulatory engagement, designed multi-setting clinical protocols, developed labeling andIFUs, and prepared submission materials.

The result: Through early FDA collaboration and statistical modeling support, we reduced trial costs by 40% and accelerated regulatory approval (time to market) by 50%.